Prudential Financial »

Enliven Therapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $548k 36k 15.40

More positions owned by Prudential Financial

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Equity Marke (DFUS)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Prudential Financial

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Vestal Point Capital
Fairmount Funds Management
BlackRock
Polar Capital Holdings
VR Adviser
Vanguard Group
Henderson Group
Point72 Asset Management
Novo A/S
Blackstone Group
Capital Research Global Investors
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics